Search

Your search keyword '"Delle-Karth, Georg"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Delle-Karth, Georg" Remove constraint Author: "Delle-Karth, Georg"
311 results on '"Delle-Karth, Georg"'

Search Results

3. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

4. A rare cardiac presentation of a lymphoma: case report.

5. Second Edition of the German–Austrian S3 Guideline “Infarction-Related Cardiogenic Shock: Diagnosis, Monitoring and Treatment”

6. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

8. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

9. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation

10. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

12. Fitness-Tracker Assisted Frailty-Assessment Before Transcatheter Aortic Valve Implantation: Proof-of-Concept Study

13. TCT-233 1-Year Outcomes After CE-Marked Approved Bicaval-Valve System Implantation in Patients With Severe Tricuspid Regurgitation

16. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

20. Not to Rush—Laboratory Parameters and Procedural Complications in Patients Undergoing Left Atrial Appendage Closure

23. One-year mortality in patients with acute ST-elevation myocardial infarction in the Vienna STEMI registry

24. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation

25. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

26. Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement

27. A Sneak-Peek into the Physician’s Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic Stenosis

28. The use of semi‐compliant versus non‐compliant balloon systems for predilatation during the implantation of self‐expandable transcatheter aortic valves

30. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention

31. Transcatheter versus Isolated Surgical Aortic Valve Replacement in Young High-Risk Patients: A Propensity Score-Matched Analysis

32. The impact of antiplatelet and antithrombotic regimen after TAVI

38. The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: Data from the VIenna Cardio Thoracic aOrtic valve registrY (VICTORY)

39. Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice

40. IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe

43. Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction

44. Impact of selected comorbidities on the presentation and management of aortic stenosis

45. The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation

50. Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis

Catalog

Books, media, physical & digital resources